ArticleOncotarget2016
An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Lu Ao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it